首页 › 转移性癌症 › 加利福尼亚州 › Mountain View
Mountain View CA 转移性癌症临床试验
25项针对 转移性癌症的研究正在 Mountain View及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
正在为研究招募参与者？将此页面置顶展示 — $99 / 30天 →
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
招募中2 期
- Stanford Cancer Institute Palo Alto, Palo Alto · 距离 5 英里
- VA Palo Alto Health Care System, Palo Alto · 距离 5 英里
Study of Orellanine in Metastatic Clear-Cell or Papillary Renal Cell Carcinoma
招募中1/2 期
- Stanford, Palo Alto · 距离 5 英里
Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors
招募中2/3 期
- Stanford Cancer Center, Palo Alto · 距离 5 英里
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
招募中3 期
- Palo Alto Medical Foundation - Palo Alto Center, Palo Alto · 距离 5 英里
A Study of Zidesamtinib (NVL-520) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ROS1 Rearrangement (ARROS-1)
招募中1/2 期
- Stanford Medicine, Palo Alto · 距离 5 英里
Safety and Preliminary Anti-Tumor Activity of TYRA-430 in Advanced Hepatocellular Carcinoma and Other Solid Tumors With Activating FGF/FGFR Pathway Aberrations
招募中1 期
- Stanford Cancer Institute, Stanford · 距离 5 英里
A Study of LY4257496 in Participants With Cancer (OMNIRAY)
招募中1 期
- Stanford University Medical Center, Stanford · 距离 5 英里
A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
招募中3 期
- Stanford Women's Cancer Center, Palo Alto · 距离 5 英里
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
招募中3 期
- Stanford Cancer Center, Palo Alto · 距离 5 英里
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
招募中1/2 期
- Stanford Cancer Institute, Stanford · 距离 5 英里
Trial Comparing LATTICE Radiotherapy vs Moderately Dose-escalated Palliative Radiation for Patients With Metastases.
招募中2 期
- Stanford University, Palo Alto · 距离 5 英里
A Phase IIIb Study to Evaluate Camizestrant Plus Ribociclib in ER-positive, HER2-negative Advanced Breast Cancer
招募中3 期
- Research Site, Palo Alto · 距离 5 英里
A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Participants With Breast Cancer
招募中1/2 期
- Stanford Cancer Institute (SCI), Stanford · 距离 5 英里
FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3
招募中1 期
- Stanford Medicine Cancer Center, Stanford · 距离 5 英里
FOG-001 in Locally Advanced or Metastatic Solid Tumors
招募中1/2 期
- Stanford Cancer Institute, Stanford University, Palo Alto · 距离 5 英里
Comparing SingLe- Vs Multi-Fraction Spine STereotActic Radiosurgery in Spinal Metastases
招募中3 期
- Stanford University School of Medicine, Palo Alto · 距离 5 英里
A Study of LY4175408 in Participants With Advanced Cancer
招募中1 期
- Stanford Medicine Cancer Center, Stanford · 距离 5 英里
A Study of Neladalkib (NVL-655) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ALK Rearrangement or Activating ALK Mutation (ALKOVE-1)
招募中1/2 期
- Stanford Cancer Institute, Stanford · 距离 5 英里
Placebo-Controlled Trial of IFx-Hu2.0 Followed By Pembrolizumab In Checkpoint Inhibitor Naïve Participants With Advanced Or Metastatic Merkel Cell Carcinoma
招募中2/3 期
- Stanford Health Care - Skin Cancer Program, Stanford · 距离 5 英里
A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma
招募中2/3 期
- Stanford Cancer Institute, Palo Alto · 距离 5 英里
Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors
招募中1 期
- Stanford Cancer Institute, Stanford · 距离 5 英里
A Study of NVL-330 in Patients With Advanced or Metastatic HER2-altered NSCLC (HEROEX-1)
招募中1 期
- Stanford Cancer Institute, Stanford · 距离 5 英里
Intra-procedural Spectral CT for Image-guided Embolization and Ablation in Interventional Oncology
招募中观察性研究
- VA Palo Alto Healthcare System, Palo Alto · 距离 5 英里
Evaluation of RBS2418 in Subjects With Advanced, Metastatic Solid Tumors
招募中1 期
- Stanford Cancer Institute, Palo Alto · 距离 5 英里
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
招募中观察性研究
- Massive Bio SYNERGY-AI site, Stanford · 距离 5 英里
其他城市的 转移性癌症试验
- Houston, TX104 项研究
- New York City, NY93 项研究
- Nashville, TN70 项研究
- Boston, MA63 项研究
- Los Angeles, CA57 项研究
- St. Louis, MO54 项研究
- Arlington, VA53 项研究
- Philadelphia, PA46 项研究
- Chicago, IL45 项研究
- San Antonio, TX44 项研究
- Washington, DC43 项研究
- Dallas, TX42 项研究
Mountain View的其他研究
- 癌症（所有类型）40 项研究
- 乳腺癌26 项研究
- 非小细胞肺癌21 项研究
- 急性髓系白血病19 项研究
- 卵巢癌19 项研究
- 自闭症谱系障碍17 项研究
- 肺癌17 项研究
- 前列腺癌15 项研究
- 心力衰竭15 项研究
- 自闭症13 项研究
- 急性淋巴细胞白血病13 项研究
- 结直肠癌13 项研究
数据来自 ClinicalTrials.gov，检索日期：2026年10月6日。每项研究自行设定入选标准，由研究团队决定谁能参与。